Concomitance of diabetic retinopathy and proteinuria accelerates the rate of decline of kidney function in type 2 diabetic patients

被引:55
作者
Trevisan, R [1 ]
Vedovato, M [1 ]
Mazzon, C [1 ]
Coracina, A [1 ]
Iori, E [1 ]
Tiengo, A [1 ]
Del Prato, S [1 ]
机构
[1] Univ Padua, Unit Metab Dis, Dept Clin & Expt Med, Padua, Italy
关键词
D O I
10.2337/diacare.25.11.2026
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE - To evaluate the rate of progression of renal disease in proteinuric type 2 diabetic patients with and without retinopathy. RESEARCH DESIGN AND METHODS - Thirty-eight proteinuric type 2 diabetic patients with diabetic retinopathy and 27 without were enrolled in an observational study for the evaluation of rate of glomerular filtration rate (GFR) decline and followed up for a median period of 6 years. GFR was determined at least once per year, and blood pressure, glycated hemoglobin, and proteinuria were determined every 4 months. RESULTS - Although the two groups had comparable GFR, albuminuria, blood pressure, and HbA(1c) at entry of the study, the rate of decline of GFR was higher in type 2 diabetic patients with retinopathy (-6.5 +/- 4.4 ml/year) than in those without (-1.8 +/- 4.8 ml/year; P < 0.0001). Protein and albumin excretion rate increased significantly in patients with retinopathy, while they did not change in those without. Mean blood pressure between the two groups of patients were similar both at entry and during the follow-up, although the proportion of patients treated with at least two antihypertensive drugs was higher in patients with retinopathy. On a multiple regression analysis, only mean blood pressure and proteinuria were significant determinants of progression of renal disease in type 2 diabetic patients with retinopathy. CONCLUSIONS - The rate of progression of renal disease in proteinuric type 2 diabetic patients with retinopathy is faster than that observed in those without retinopathy. The screening for retinopathy identifies patients at high risk for rapid deterioration of kidney function.
引用
收藏
页码:2026 / 2031
页数:6
相关论文
共 28 条
[1]  
Alaveras AEG, 1997, NEPHROL DIAL TRANSPL, V12, P71
[2]  
[Anonymous], USRDS 1999 ANN DAT R
[3]   Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy [J].
Brenner, BM ;
Cooper, ME ;
de Zeeuw, D ;
Keane, WF ;
Mitch, WE ;
Parving, HH ;
Remuzzi, G ;
Snapinn, SM ;
Zhang, ZX ;
Shahinfar, S .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (12) :861-869
[4]  
BROCHNERMORTENS.J, 1969, SCAND J CLIN LAB INV, V26, P5
[5]   Causes of albuminuria in patients with type 2 diabetes without diabetic retinopathy [J].
Christensen, PK ;
Larsen, S ;
Horn, T ;
Olsen, S ;
Parving, HH .
KIDNEY INTERNATIONAL, 2000, 58 (04) :1719-1731
[6]  
Christensen PK, 2000, DIABETES CARE, V23, pB14
[7]   Patterns of renal injury in NIDDM patients with microalbuminuria [J].
Fioretto, P ;
Mauer, M ;
Brocco, E ;
Velussi, M ;
Frigato, F ;
Muollo, B ;
Sambataro, M ;
Abaterusso, C ;
Baggio, B ;
Crepaldi, G ;
Nosadini, R .
DIABETOLOGIA, 1996, 39 (12) :1569-1576
[8]   THE COURSE OF KIDNEY-FUNCTION IN TYPE-2 (NON-INSULIN-DEPENDENT) DIABETIC-PATIENTS WITH DIABETIC NEPHROPATHY [J].
GALL, MA ;
NIELSEN, FS ;
SMIDT, UM ;
PARVING, HH .
DIABETOLOGIA, 1993, 36 (10) :1071-1078
[9]   Risk factors for development of incipient and overt diabetic nephropathy in patients with non-insulin dependent diabetes mellitus: Prospective, observational study [J].
Gall, MA ;
Hougaard, P ;
BorchJohnsen, K ;
Parving, HH .
BMJ-BRITISH MEDICAL JOURNAL, 1997, 314 (7083) :783-788
[10]   PREVALENCE OF MICROALBUMINURIA AND MACROALBUMINURIA, ARTERIAL-HYPERTENSION, RETINOPATHY AND LARGE VESSEL DISEASE IN EUROPEAN TYPE-2 (NON-INSULIN-DEPENDENT) DIABETIC-PATIENTS [J].
GALL, MA ;
ROSSING, P ;
SKOTT, P ;
DAMSBO, P ;
VAAG, A ;
BECH, K ;
DEJGAARD, A ;
LAURITZEN, M ;
LAURITZEN, E ;
HOUGAARD, P ;
BECKNIELSEN, H ;
PARVING, HH .
DIABETOLOGIA, 1991, 34 (09) :655-661